VHIO’s multidisciplinary teams collaborate through dedicated Task Forces (TFs), coordinated by VHIO’s Scientific Management Area, to align research initiatives with the institute’s strategic vision and core priorities. These teams are designed to foster interaction among professionals from various oncology-related fields, including biomedical researchers, clinical investigators, pathologists, along with specialists from different medical disciplines, spanning clinical research nurses, data specialists, study coordinators, and project managers.

Currently, VHIO’s TFs encompass multiple tumor types, including breast, colorectal, gastroesophageal, neuroendocrine, rectal, pancreatic, gynecological, and biliary tract cancers, among others, as well as transversal areas such as imaging, liquid biopsy and patient engagement. This structure ensures a comprehensive and integrated approach to clinical and translational challenges in oncology.

In the last years, VHIO has strengthened its TF structure to enhance impact and efficiency, and several TFs have been reconfigured to better align with the evolving structure of VHIO’s research groups, ensuring improved coordination and integration across programs.

Each TF is led by an appointed Chair and supported by a project manager responsible for ensuring smooth coordination. Their role includes setting meeting agendas, compiling minutes, following up on action points, and fostering synergies across VHIO’s investigators, within and beyond TF participants. The structure and activity level of each TF vary depending on their size, workflow, and participant engagement. This flexible and adaptive structure allows VHIO’s TFs to continuously evolve and address emerging research needs.

VHIO’s TFs also serve as a platform for fostering collaborative research across institutions. Clinical investigators from Vall d’Hebron and other hospitals in Catalonia, along with translational researchers from the Vall d’Hebron Barcelona Hospital Campus and other research centers, actively contribute to these initiatives, promoting multidisciplinary collaboration and knowledge exchange.

VHIO aims to consolidate the recently established and restructured TFs, ensuring their full integration within the institutional research framework. Efforts will focus on optimizing their operational performance and further adapting TF structures to the evolving scientific and organizational priorities. This approach will support sustained progress in precision oncology and maximize the impact of collaborative research on patient care.